p53は,肺がん抑制におけるAT1分化プログラムを管理する

Alyssa M Kaiser¹, Alberto Gatto², Kathryn J Hanson^1,3

¹Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.

Nature

|July 19, 2023

まとめ

腫瘍抑制剤p53 (TP53としても知られる) は,肺腺がん (LUAD) を予防し,胞細胞の分化を促進する. p53の機能の喪失は,持続的な癌細胞と腫瘍の成長につながります.

科学分野:

腫瘍学
分子生物学
細胞生物学

背景:

肺がん,特に肺腺癌 (LUAD) は,世界中で癌による死亡の主な原因です.
TP53腫瘍抑制遺伝子の変異は,LUADで頻繁に見られ,患者の悪い結果と関連しています.
p53がLUADの発達を抑制する正確なメカニズムは,ほとんど不明のままである.

研究の目的:

肺腺がん (LUAD) の抑制における腫瘍抑制剤p53の役割を解明する.
LUADの文脈でp53が細胞状態と分化にどのように影響するか調査する.
膜再生におけるp53の機能とそのLUAD抑制への影響を理解する.

主な方法:

腫瘍性Krasを発現するアルベオラ型2 (AT2) 細胞に異なるTrp53アレルを持つ遺伝子組み換えマウスモデルを使用した.
RNAシーケンシングとATACシーケンシングを使用して,LUAD細胞を分析し,p53調節された遺伝子発現とクロマチンのアクセシビリティを特定しました.
LUADの進化とアルベオラの修復過程における細胞状態と分化ダイナミクスを調べるために単細胞トランスクリプトミクスを実施した.

主要な成果:

p53は,直接DNA結合とクロマチンの改造を含むプロセスであるアルベオラ1型 (AT1) 細胞の分化を促進することによって,LUADを抑制する.
p53の無活性化により,異常な移行期がん細胞が増加し,LUADの進行が促進されます.
p53は,AT2細胞の自己再生を制御し,AT1細胞への移行細胞の分化を促進することによって,膜再生にも重要な役割を果たします.

結論:

p53は,細胞状態を制御し,特にトランジション細胞中間体を通してAT1の分化を促進することによって,肺腺がんを抑制する.
LUADにおけるp53の腫瘍抑制機能は,組織修復と胞再生の調整における基本的な役割と関連しています.
これらの発見は,p53媒介の腫瘍抑制に関する新しい洞察を明らかにし,LUADの細胞分化経路を標的とした治療戦略を示唆する.

さらに関連する動画

17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

12.4K

06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

17.1K

関連する概念動画

02:23

Abnormal Proliferation

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

4.6K

01:23

Negative Regulator Molecules

35.5K

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.

35.5K

01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.1K

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

2.1K

02:37

DNA Damage can Stall the Cell Cycle

9.2K

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

9.2K

01:19

Interactions Between Signaling Pathways

6.3K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

6.3K

01:31

The Intrinsic Apoptotic Pathway

6.6K

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...